title: Bullous systemic lupus erythematosus.
abstract: Two patients with bullous systemic lupus erythematosus are reported. In one, the disease appears to have been caused by hydralazine. The cutaneous lesions of bullous SLE have not been previously reported in drug-induced lupus.
authors.affiliation: Department of Dermatology, Cleveland Clinic Foundation, Ohio 44106.
authors.forename: M G
authors.initials: MG
authors.lastname: Fleming
authors.forename: W F
authors.initials: WF
authors.lastname: Bergfeld
authors.forename: K J
authors.initials: KJ
authors.lastname: Tomecki
authors.forename: R J
authors.initials: RJ
authors.lastname: Tuthill
authors.forename: M
authors.initials: M
authors.lastname: Norris
authors.forename: E A
authors.initials: EA
authors.lastname: Benedetto
authors.forename: L A
authors.initials: LA
authors.lastname: Weber
mesh_terms: D000328:Adult; D000368:Aged; D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000150:complications* / Q000473:pathology; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced / Q000150:complications* / Q000276:immunology / Q000473:pathology
chemical_list: D006830:Hydralazine; D003622:Dapsone